D. E. Shaw & Co., Inc. - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 107 filers reported holding HOMOLOGY MEDICINES INC in Q1 2022. The put-call ratio across all filers is 4.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q2 2022$443,000
-20.0%
225,047
+23.6%
0.00%0.0%
Q1 2022$554,000
+63.9%
182,046
+96.4%
0.00%
Q4 2021$338,000
-83.1%
92,708
-63.5%
0.00%
-100.0%
Q3 2021$2,001,000
+1.2%
254,263
-6.5%
0.00%0.0%
Q2 2021$1,977,000
+280.9%
271,932
+392.7%
0.00%
+100.0%
Q1 2021$519,000
+13.8%
55,197
+36.7%
0.00%
Q4 2020$456,000
-57.5%
40,375
-42.9%
0.00%
-100.0%
Q2 2020$1,073,00070,6640.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q1 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$5,307,0251.53%
Western Standard LLC 250,060$292,5700.26%
OUP Management Co., LLC 64,000$74,8800.17%
Vivo Capital, LLC 370,068$432,9800.05%
Temasek Holdings (Private) Ltd 5,650,996$6,611,6650.04%
GEORGE KAISER FAMILY FOUNDATION 39,320$46,0040.01%
American Investment Services, Inc. 36,955$43,2380.01%
RBF Capital, LLC 58,700$68,6790.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 185,100$216,5670.01%
XTX Topco Ltd 21,188$24,7900.00%
View complete list of HOMOLOGY MEDICINES INC shareholders